From Vision to Validation: How Biotechs Can Win in Today’s Precision Capital Market
Biotech financing is beginning to rebound, but not across the board. According to June 2025 data, public biotech fundraising surpassed private for the first time
Biotech financing is beginning to rebound, but not across the board. According to June 2025 data, public biotech fundraising surpassed private for the first time

Quality infrastructure is an essential foundation for success in radiopharmaceutical and cell & gene therapy manufacturing. To meet modern industry expectations, companies must transition away

Radiopharmaceuticals Are Changing the Game Radiopharmaceuticals are at the forefront of modern medicine and are changing the way we fight complex cancers. These novel compounds

The innovative treatments of today demand complex and carefully considered manufacturing facilities. An autologous cell therapy manufacturing facility must ensure patient safety, product integrity, and